I agree that this site is using cookies. You can find further informations here.
X
Clemow, David B
50  results:
Search for persons X
?
1

Two-Year Efficacy and Safety of Mirikizumab Following 104 W..:

Sands, Bruce E ; D'Haens, Geert ; Clemow, David B...
Inflammatory Bowel Diseases.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Su1814 CLINICAL RELEVANCE OF BASELINE AND CHANGE IN URGENCY..:

Clemow, David B. ; Dubinsky, Marla C. ; Baygani, Simin...
Gastroenterology.  166 (2024)  5 - p. S-826 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Clinical Effect of Mirikizumab Treatment on Bowel Urgency i..:

Dubinsky, Marla C ; Clemow, David B ; Hunter Gibble, Theresa...
Crohn's & Colitis 360.  5 (2022)  1 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
4

Effect of a change in lasmiditan dose on efficacy and safet..:

Clemow, David B. ; Hochstetler, Helen M. ; Dong, Yan...
Postgraduate Medicine.  133 (2021)  4 - p. 449-459 , 2021
Link: https://doi.org/10.1080/..
 
?
5

Lasmiditan in patients with common migraine comorbidities: ..:

Clemow, David B. ; Baygani, Simin K. ; Hauck, Paula M..
Current Medical Research and Opinion.  36 (2020)  11 - p. 1791-1806 , 2020
Link: https://doi.org/10.1080/..
 
?
6

Lasmiditan mechanism of action – review of a selective 5-HT..:

Clemow, David B. ; Johnson, Kirk W. ; Hochstetler, Helen M....
The Journal of Headache and Pain.  21 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
?
7

Medical Writing Competency Model — Section 1: Functions, Ta..:

Clemow, David B. ; Wagner, Bertil ; Marshallsay, Christopher...
Therapeutic Innovation & Regulatory Science.  52 (2018)  1 - p. 70-77 , 2018
Link: https://doi.org/10.1177/..
 
?
8

Medical Writing Competency Model — Section 2: Knowledge, Sk..:

Clemow, David B. ; Wagner, Bertil ; Marshallsay, Christopher...
Therapeutic Innovation & Regulatory Science.  52 (2018)  1 - p. 78-88 , 2018
Link: https://doi.org/10.1177/..
 
?
9

Clinical Impact of Not Achieving Recommended Dose on Durati..:

Clemow, David B. ; Nyhuis, Allen W. ; Robinson, Rebecca L.
CNS Neuroscience & Therapeutics.  22 (2016)  12 - p. 970-978 , 2016
Link: https://doi.org/10.1111/..
 
?
10

Atomoxetine Increased Effect over Time in Adults with Atten..:

Wietecha, Linda A. ; Clemow, David B. ; Buchanan, Andrew S....
CNS Neuroscience & Therapeutics.  22 (2016)  7 - p. 546-557 , 2016
Link: https://doi.org/10.1111/..
 
?
11

Real‐World Dosing Patterns of Atomoxetine in Adults with At..:

Kabul, Samaneh ; Alatorre, Carlos ; Montejano, Leslie B...
CNS Neuroscience & Therapeutics.  21 (2015)  12 - p. 936-942 , 2015
Link: https://doi.org/10.1111/..
 
?
12

Medicines in Pregnancy Forum: Proceedings on Ethical and Le..:

Clemow, David B. ; Nolan, Martha R. ; Michaels, Debra L....
Therapeutic Innovation & Regulatory Science.  49 (2015)  3 - p. 326-332 , 2015
Link: https://doi.org/10.1177/..
 
?
13

Atomoxetine in patients with ADHD: A clinical and pharmacol..:

Clemow, David B ; Bushe, Chris J
Journal of Psychopharmacology.  29 (2015)  12 - p. 1221-1230 , 2015
Link: https://doi.org/10.1177/..
 
?
14

Clinical Data for Informed Medication Use in Pregnancy: Str..:

Clemow, David B. ; Dewulf, Lode ; Koren, Gideon...
Therapeutic Innovation & Regulatory Science.  48 (2014)  2 - p. 134-144 , 2014
Link: https://doi.org/10.1177/..
 
?
15

A Proposed Framework to Address Needs of Clinical Data for ..:

Clemow, David B. ; Dewulf, Lode ; Michaels, Debra L....
Therapeutic Innovation & Regulatory Science.  48 (2014)  2 - p. 145-154 , 2014
Link: https://doi.org/10.1177/..
 
1-15